Clinical trial
AVN Prevention With Lipitor in Lupus Erythematosus APLLE Trial
NCT00412841 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- AVN Prevention With Lipitor in Lupus Erythematosus APLLE Trial
- Lead sponsor
- NYU Langone Health
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- November 30, 2002
- Completion date
- January 31, 2008
- Enrollment
- 43 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
avascular necrosis